About IMI
 

Home

News

26.02.2016

On 18–19 February, 2016, we celebrated the successful completion of the Open PHACTS project with a conference on linking life science data in Vienna, Austria.

79 attendees from a broad cross-section of backgrounds gathered to discuss what lessons have been learned from the success of Open PHACTS, and how the Open PHACTS Foundation will take the project’s outcomes forward.

Read more...

05.02.2016

A long-time partner of the Open PHACTS project, the University of Vienna has committed to supporting the Open PHACTS Foundation as our first academic member. Professor Gerhard Ecker and his colleagues bring a wealth of expertise and experience in linked pharmacological data to the Foundation, and we are excited about working together to continue building on the achievements of Open PHACTS.

Read more...

04.02.2016

Contents

  • API 2.0 is here
  • Decommissioning API 1.4
  • Upcoming conference: Linking Life Science Data
  • New Foundation member: University of Vienna
Read more...

29.01.2016

We’re excited to announce the official release of version 2.0 of the Open PHACTS API, along with major updates to the linked data in the Open PHACTS Discovery Platform.

Try out API version 2.0 now

Read more...

28.01.2016

There are just three weeks to go until our conference, Linking Life Science Data: From Design to Implementation, and Beyond. If you haven’t yet registered, attendance is free and there are still places available:

Register now

Read more...

The Open PHACTS Discovery Platform has been developed to reduce barriers to drug discovery in industry, academia and for small businesses. You can now access the integrated pharmacological data via the Open PHACTS API, Open PHACTS Explorer or apps

 

 “Open PHACTS is enabling you to do what you do best!”

 

 

The Open PHACTS project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115191, resources of which are composed of financial contribution from the European Unions's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.

This website reflects only the author's views and neither IMI nor the European Commission is liable for any use that may be made of the information contained therein.